At a recent conference in Seoul, the Korean Cannabinoid Association, or KCA, announced that it planned to initiate a project that would carry out clinical pilots that utilised cannabidiol, or CBD, a derivative of cannabis that has been widely used in the treatment of epilepsy and multiple sclerosis.
The KCA plans to launch the new pilot project in a novel way too. They’ll be using Prasm, a decentralised bioinformatics network that leverages both blockchain technology and artificial intelligence (AI).
KCA President explains the project
The director of Prasm and the president of the KCA, Kwon Yong-hyun explained a little more about the project, saying that due to the overriding prejudice that many believe hemp to be a drug, the Korean medical fraternity has been reluctant to conduct clinical studies that would prove that hemp has therapeutic properties when used medicinally. He added that he knew that the public was concerned about the abuse of marijuana and during any voluntary or paid medical trials this would be considered. If the drugs pass, the release of them on to the market would be governed by strict controls and require prescriptions.
Several trials undertaken
For those who are interested in drug trials like the ones run by an entity like Paid Medical Trials Trials4us, the KCA’s will be similar, but they’ll be using blockchain to record all patient data. Data will be recorded biometrically, using wearable systems, and the information gathered added to the blockchain. The data received will then be collated and help the KCA determine the correct prescription and dosage.
Blockchain is increasingly being put forward as a data collection and storage option for drug trials and the fact that it is largely anonymous, decentralised and very secure, makes it very appealing. Mr Yong-hyun weighed in on using blockchain technology for the upcoming trials, saying that it was ideal for tracking medicinal hemp use, as the data cannot be altered in any way, and is thus the most accurate option, as it also reveals key information about patient illnesses at the same time.
He hopes that by using blockchain technology all concerns related to the abuse of marijuana, medical or otherwise, will be alleviated. He also hopes the trials will go a long way to legalising hemp in South Korea and changing the way people see it.